Medical Pharmacology Chapter 36: Antiviral Drugs
Viral Structure continued:
Viral Envelope Proteins: Some but not all animal viruses have envelopes, including those viruses exhibiting helical symmetry (influenza viruses and others) and many showing icosahedral symmetry (herpesviruses and others).1
Envelope viral membranes include associated proteins.1
These proteins are typically integral membrane proteins and many have been glycosylated.
Glycoproteins in virion envelopes often present as repeating units, described as multimeric.
One example, influenza A contains to glycoprotein species, one trimeric (hemagglutinin) and the second, a neuraminidase (tetrameric).
A nonglycosylated, additional protein species (M2) is also found.1
Many membrane associated proteins are found to span the membrane, such as those associated with signal transduction e.g. G proteins.
However, envelope proteins may span the membrane only once although hepatitis B virus is an example of one spanning the membrane several times.1
Envelope virus surface glycoproteins may assist in fusing virion membrane to cell membrane during infection.
Envelope viruses such as influenza viruses and retroviruses exhibit a protein layer between the envelope in the nucleocapsid.1
This layer consists of "matrix protein" or M protein.1
|
|
The molecular structure of several matrix proteins which belong to the order Mononegavirales [respiratory syncytial virus (RSV), Ebola virus and Borna virus] have been determined.2
These structures exhibit one or two domains with similar β-sandwich stuctures.
Paramyxovirus M protein may form a grid-like structure on the viral membrane inner surface.
Paramyxoviruses include human pathogens affecting the respiratory system.
Newcastle disease virus (NDV) is an avian Paramyxovirus.
The NDV M protein shows >20% sequence identity with other Paramyxovirus M protein such as mumps, measles and the parainfluenza viruses.2
Other viruses not exhibiting this layer shows direct nucleocapsid interaction with integral membrane proteins.
The viral envelope contains lipid which is acquired during the process in which viral nucleocapsids bud through cellular membrane.
|
|
|
This process occurs during viral maturation and the site of binding is determined by viral proteins inserted into the host cell membrane.4,5
Virion membrane phospholipid composition is therefore determined in part by the lipid composition characteristics of the host cell.
An example of this process is found in the HIV-1 envelope; moreover, the virion membrane albeit derived from host cell membranes undergoes modification prior to incorporation.
In the HIV-1 case the viral envelope contains relatively more cholesterol and sphingomyelin compared to the plasma cell membrane but less phosphatidylcholine and phosphatidylinositol.
Another factor is which cellular membrane is used in the budding process.6
For instance, influenza virus buds outward from the cell surface and reflects cholesterol and phospholipid concentrations consistent with those proportions found in the plasma membrane.
By contrast, flaviviruses but into the endoplasmic reticulum and exhibits relatively lower cholesterol content consistent with the lipid composition of the endoplasmic reticulum membrane.
The viral genome is protected from the environment in part by the lipid bilayer which acts as a permeability barrier.
Therefore, enveloped viruses may exhibit reduced safety-margin with respect to protein assembly compared to non-enveloped viruses.6
Viruses that replicate in more than one kind of host cell will exhibit different envelope lipid compositions depending on the host cell type.
For example, the alphavirus Semliki Forest virus hosted by hamster kidney cells contain fivefold more cholesterol compared to virions produced in mosquito cells.
|
|
Furthermore, acquiring the lipid-containing membrane is a central step in virion morphogenesis in some viruses.
Some lipid-containing viruses may be disrupted to the point of loss of infectivity by exposure to organic solvents such as ether.4,5
|
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information. Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals. |